All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

111

Reset

111 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • BrenipatideLY3537031Phase 313 trials

    Eli Lilly · Alcohol Use Disorder, Irritable Bowel Syndrome, Depressive Disorder, Major

  • AzetukalnerXEN1101Phase 39 trials

    Xenon Pharmaceuticals Inc. · Focal Onset Seizures, Major Depressive Disorder, Bipolar Disorder

  • KarX-ECBMS-986519, Xanomeline Enteric-coatedPhase 39 trials

    Bristol Myers Squibb · Alzheimer Disease, Alzheimer's Disease, Irritability Associated With Autism Spectrum Disorder

  • SEP-363856UlotarontPhase 37 trials

    Otsuka · Generalized Anxiety Disorder, Schizophrenia, Major Depressive Disorder

  • BHV-7000Phase 36 trials

    Biohaven Therapeutics Ltd. · Focal Epilepsy, Major Depressive Disorder, Bipolar Disorder

  • ITI-1284JNJ-99245354Phase 36 trials

    Intra-Cellular Therapies, Inc. · Generalized Anxiety Disorder, Agitation Associated With Alzheimer's Dementia, Psychotic Disorders

  • MazdutideLY3305677Phase 35 trials

    Eli Lilly · Type 2 Diabetes, Obesity, Overweight

  • NBI-1065845TAK-653, OsavampatorPhase 35 trials

    Neurocrine Biosciences · Major Depressive Disorder

  • NBI-1117568Phase 35 trials

    Neurocrine Biosciences · Schizophrenia, Bipolar I Disorder, Mania

  • RAP-219Phase 35 trials

    Rapport Therapeutics Inc. · Focal Epilepsy, Epilepsy, Focal Seizure

  • ACP-204Phase 34 trials

    ACADIA Pharmaceuticals Inc. · Alzheimer's Disease Psychosis, Lewy Body Dementia Psychosis

  • CebranopadolTRN-228Phase 34 trials

    Adneuris Therapeutics, Inc. · Pain, Acute Pain, Chronic Pain

  • CYM-53093Navacaprant, NMRA-335140Phase 34 trials

    Neumora Therapeutics, Inc. · Major Depressive Disorder, Major Depressive Episode Associated With Bipolar II Disorder

  • DT120MM120, lysergide tartratePhase 34 trials

    Definium Therapeutics US, Inc. · Generalized Anxiety Disorder, Major Depressive Disorder

  • KH607Phase 34 trials

    Chengdu Kanghong Pharmaceutical Group Co., Ltd. · Major Depressive Disorder (MDD), Postpartum Depressive Disorder

  • LB-102Phase 34 trials

    LB Pharmaceuticals Inc. · Schizophrenia, Bipolar I Disorder

  • PemvidutidePhase 34 trials

    Altimmune, Inc. · Alcohol-associated Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Alcohol Use Disorder (AUD)

  • PsilocybinCOMP360Phase 34 trials

    COMPASS Pathways · Treatment Resistant Depression, Major Depressive Disorder, Anorexia Nervosa

  • AXS-05dextromethorphan-bupropionPhase 33 trials

    Axsome Therapeutics, Inc. · Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer Disease, Smoking Cessation

  • CYB003Phase 33 trials

    Cybin IRL Limited · Major Depressive Disorder, Major Depressive Disorder (MDD), Depression in Adults

  • HS-10380Phase 33 trials

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · SCHIZOPHRENIA 1 (Disorder)

  • SPG302TazbentetolPhase 33 trials

    Spinogenix · Alzheimer Disease, Schizophrenia, Amyotrophic Lateral Sclerosis

  • TJ0113Phase 33 trials

    Hangzhou PhecdaMed Co., Ltd. · Sarcopenia, Parkinson's Disease (PD), Parkinson Disease 6, Early-Onset

  • BuagafuranPhase 32 trials

    Beijing Union Pharmaceutical Factory Ltd · Generalized Anxiety Disorder

  • Buagafuran mimicPhase 32 trials

    Beijing Union Pharmaceutical Factory Ltd · Generalized Anxiety Disorder

  • FasedienolPhase 32 trials

    VistaGen Therapeutics, Inc. · Social Anxiety Disorder, Social Anxiety Disorder (SAD)

  • HS-10506Phase 32 trials

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Insomnia Disorder

  • MI078Phase 32 trials

    Nanjing Minova Pharmaceutical Co., Ltd. · Postpartum Depression (PPD), Postpartum Depression

  • OLZSAM, ALKS 3831Phase 32 trials

    Alkermes, Inc. · Bipolar I Disorder, Schizophrenia

  • PBOPhase 32 trials

    SK Life Science, Inc. · Primary Generalized Epilepsy, Treatment Resistant Depression

  • SeltorexantJNJ 42847922Phase 32 trials

    Johnson & Johnson (Janssen) · Depressive Disorder, Major

  • B2227Phase 31 trial

    Bostal Drug Delivery Co., Ltd · Schizophrenia

  • BNC210Phase 31 trial

    Bionomics Limited · Social Anxiety Disorder

  • CSPC Ouyi Pharmaceutical Co., Ltd. · Major Depressive Disorder (MDD)

  • EXV-801deramciclanePhase 31 trial

    Exciva GmbH · Agitation Associated With Alzheimer's Disease Dementia

  • EXV-802Phase 31 trial

    Exciva GmbH · Agitation Associated With Alzheimer's Disease Dementia

  • NRX-101Phase 31 trial

    NeuroRx, Inc. · Treatment Resistant Depression, Treatment Resistant Depression (TRD)

  • SUVN-502MasupirdinePhase 31 trial

    Suven Life Sciences Limited · Agitation, Alzheimer's Type Dementia

  • Luye Pharma Group Ltd. · Generalized Anxiety Disorder

  • VQW-765Phase 31 trial

    Vanda Pharmaceuticals · Social Anxiety Disorder (SAD)

  • YZJ-1139Phase 31 trial

    Shanghai Haiyan Pharmaceutical Technology Co., Ltd. · Insomnia Disorder

  • ONO-1110Phase 25 trials

    Ono Pharmaceutical Co., Ltd. · Fibromyalgia, Social Anxiety Disorder (SAD), Major Depressive Disorder (MDD

  • ML-007C-MAPhase 24 trials

    MapLight Therapeutics · Psychosis Associated With Alzheimer's Disease, Schizophrenia

  • ABBV-932Phase 23 trials

    AbbVie · Bipolar I or II Disorder, Generalized Anxiety Disorder (GAD), Bipolar I Disorder

  • AL-001lithium salicylate, L-proline cocrystalPhase 23 trials

    Beijing Anlong Biopharmaceutical Co., Ltd. · Wet Age-related Macular Degeneration (wAMD), Bipolar I Disorder

  • ENX-102ENX-102 -dose, ENX-102 mid-dosePhase 23 trials

    Engrail Therapeutics INC · General Anxiety Disorder, Social Anxiety Disorder (SAD), Generalized Anxiety Disorder

  • RE104Phase 23 trials

    Reunion Neuroscience Inc · Adjustment Disorder, Generalized Anxiety Disorder, Postpartum Depression

  • ABX-002Phase 22 trials

    Autobahn Therapeutics, Inc. · Major Depressive Disorder, Bipolar Disorder Depression

  • AFA-281Phase 22 trials

    Afasci Inc · Alcohol Abuse, Alcohol Abuse/addiction, Anxiety

  • BI 1569912Phase 22 trials

    Boehringer Ingelheim · Depressive Disorder, Major

Page 1 of 3Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.